About The Elliot Lewis Center for Multiple Sclerosis Care
"The Elliot Lewis Center for Multiple Sclerosis Care is one of the largest multiple sclerosis centers in the metro Boston area and in all of New England. The Center offers state-of-the-art medical care, including diagnosis, symptom management, access to all approved disease modifying treatments, on-site infusion suite, social work, and the latest clinical research trials."
Clinical Trials at The Elliot Lewis Center for Multiple Sclerosis Care
During the past decade, The Elliot Lewis Center for Multiple Sclerosis Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "The Elliot Lewis Center for Multiple Sclerosis Care"
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at The Elliot Lewis Center for Multiple Sclerosis Care
According to Clinical.Site data, the most researched conditions in "The Elliot Lewis Center for Multiple Sclerosis Care" are
"Multiple Sclerosis" (2 trials) and "Radiologically Isolated Syndrome" (1 trials). Many other conditions were trialed in "The Elliot Lewis Center for Multiple Sclerosis Care" in a lesser frequency.
Clinical Trials Intervention Types at The Elliot Lewis Center for Multiple Sclerosis Care
Most popular intervention types in "The Elliot Lewis Center for Multiple Sclerosis Care" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cladribine Tablets" (1 trials), "Ocrelizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Elliot Lewis Center for Multiple Sclerosis Care
The vast majority of trials in "The Elliot Lewis Center for Multiple Sclerosis Care" are
2 trials for "All" genders.
Clinical Trials Status at The Elliot Lewis Center for Multiple Sclerosis Care
Currently, there are NaN active trials in "The Elliot Lewis Center for Multiple Sclerosis Care".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in The Elliot Lewis Center for Multiple Sclerosis Care,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Elliot Lewis Center for Multiple Sclerosis Care, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".